# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA4268661 | F | Potency index, ratio of 5-fluorouracil IC50 to test compound IC50 for human A549 cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
2. | ALA4268662 | F | Potency index, ratio of 5-fluorouracil IC50 to test compound IC50 for human MCF7 cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
3. | ALA4268663 | F | Potency index, ratio of 5-fluorouracil IC50 to test compound IC50 for human T84 cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
4. | ALA4268664 | F | Antiproliferative activity against human MCF7 cells after 3 days by sulforhodamine B assay | Homo sapiens | 9 | cell-based format | Scientific Literature | ||
5. | ALA4268665 | F | Antiproliferative activity against human T84 cells after 3 days by sulforhodamine B assay | Homo sapiens | 9 | cell-based format | Scientific Literature | ||
6. | ALA4268666 | F | Antiproliferative activity against human A549 cells after 3 days by sulforhodamine B assay | Homo sapiens | 9 | cell-based format | Scientific Literature | ||
7. | ALA4268668 | A | Cytotoxicity against human PBMC assessed as reduction in cell viability at 10 uM by MTT assay relative to control | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
8. | ALA4268669 | A | Cytotoxicity against human PBMC assessed as cell viability at 1 uM by MTT assay relative to control | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
9. | ALA4268670 | A | Cytotoxicity against human PBMC assessed as cell viability at 2.5 uM by MTT assay relative to control | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
10. | ALA4268671 | A | Cytotoxicity against human PBMC assessed as cell viability at 5 uM by MTT assay relative to control | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
11. | ALA4268673 | F | Cell cycle arrest in human A549 cells assessed as accumulation at G2/M phase at IC50 after 24 hrs by propidium iodide staining based flow cytometry (Rvb = 8.8%) | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
12. | ALA4268674 | F | Cell cycle arrest in human A549 cells assessed as accumulation at G0/G1 phase at IC50 after 24 hrs by propidium iodide staining based flow cytometry (Rvb = 60.6%) | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
13. | ALA4268675 | F | Cell cycle arrest in human A549 cells assessed as accumulation at sub-G1 phase at IC50 after 48 hrs by propidium iodide staining based flow cytometry (Rvb = 2.6%) | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
14. | ALA4268676 | F | Cell cycle arrest in human A549 cells assessed as reduction in accumulation at G1 phase at IC50 after 48 hrs by propidium iodide staining based flow cytometry | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
15. | ALA4268677 | F | Cell cycle arrest in human A549 cells assessed as reduction in accumulation at S phase at IC50 after 48 hrs by propidium iodide staining based flow cytometry | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
16. | ALA4268678 | F | Cell cycle arrest in human A549 cells assessed as reduction in accumulation at G2/M phase at IC50 after 48 hrs by propidium iodide staining based flow cytometry | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
17. | ALA4268679 | F | Induction of apoptosis in human A549 cells assessed as viable cells at IC50 after 24 hrs by Annexin-V-FITC/propidium iodide staining based flow cytometry (Rvb = 83.6%) | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
18. | ALA4268680 | F | Induction of apoptosis in human A549 cells assessed as total apoptotic cells at IC50 after 24 hrs by Annexin-V-FITC/propidium iodide staining based flow cytometry (Rvb = 13.2%) | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
19. | ALA4268681 | F | Induction of apoptosis in human A549 cells assessed as increase in Bax to Bcl2 ratio at 0.5 to 1 times IC50 after 24 hrs Western blot analysis | Homo sapiens | 1 | cell-based format | Scientific Literature |